B. Kusserow Paul - 17 Feb 2022 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
CEO and Chairman of the Board, Director
Signature
/s/ Jennifer R. Guckert, pursuant to a power of attorney
Issuer symbol
AMED
Transactions as of
17 Feb 2022
Net transactions value
-$2,767,304
Form type
4
Filing time
22 Feb 2022, 20:00:40 UTC
Previous filing
10 Jan 2022
Next filing
28 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Options Exercise $0 +49,092 +14% $0.000000 398,663 17 Feb 2022 Direct F1
transaction AMED Common Stock Tax liability $1,383,652 -9,659 -2.4% $143.25 389,004 17 Feb 2022 Direct
transaction AMED Common Stock Tax liability $1,383,652 -9,659 -2.5% $143.25 379,345 17 Feb 2022 Direct
holding AMED Common Stock 83,764 17 Feb 2022 By Trust
holding AMED Common Stock 621 17 Feb 2022 Through 401(k) Plan F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMED Restricted Stock Units Options Exercise $0 -73,638 -100% $0.000000* 0 17 Feb 2022 Common Stock 73,638 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 2, 2019, the Reporting Person was awarded 73,638 performance-based Restricted Stock Units ("RSUs") with vesting based on certification of achievement of identified performance goals for each of fiscal years 2019 through 2021 (1/3 of the RSUs vest, if at all, based on achievement of the 2019 performance goal; 1/3 of the RSUs vest, if at all, based on achievement of the 2020 performance goal; and 1/3 of the RSUs vest, if at all, based on achievement of the 2021 performance goal). The Compensation Committee of the Issuer has certified achievement of the 2019 and 2020 performance measures, but the 2021 performance measure was not satisfied, thereby resulting in the Reporting Person earning 49,092 shares of common stock, which are reported in Table I.
F2 The information in this report is based on a plan statement dated as of December 31, 2021.

Remarks:

CEO and Chairman of the Board